Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The New York-based startup, which is backed by $500 million in venture capital, announced new topline data from its Phase 1 trial of MET-233i, an ultra-long-acting amylin analog designed to pair with its
Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation
He said that the pathophysiology of NAION itself is unclear, and no one mechanism has been definitively demonstrated
The risk was not statistically significant compared to non-users
Comment Provided 2018 manufactured tablets
In this review, we summarized the last advances in our knowledge about the role of glutamine metabolism in cancer therapy
US$ 29.14
US$ 23.86
US$ 20.79
US$ 22.34
